🇺🇸 FDA
Pipeline program

Mifepristone

C-1073-200

Phase 2 small_molecule completed

Quick answer

Mifepristone for Weight-Gain Prevention is a Phase 2 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CORCEPT THERAPEUTICS INC
Indication
Weight-Gain Prevention
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials